Get the Stockscreener App
18.94
0.53%
0.10
Pre-market:
17.94
-1.00
-5.28%
Tandem Diabetes Care Inc stock is traded at $18.94, with a volume of 1.52M.
It is up +0.53% in the last 24 hours and down -6.05% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$18.84
Open:
$19.14
24h Volume:
1.52M
Relative Volume:
0.97
Market Cap:
$1.28B
Revenue:
$796.00M
Net Income/Loss:
$-136.49M
P/E Ratio:
-9.0622
EPS:
-2.09
Net Cash Flow:
$-64.24M
1W Performance:
-3.66%
1M Performance:
-6.05%
6M Performance:
+74.72%
1Y Performance:
-41.94%
1-Day Range:
$18.45
$19.26
1-Week Range:
$18.34
$19.81
52-Week Range:
$9.98
$35.12
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
18.94 | 1.28B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Resumed | TD Cowen | Buy |
| Dec-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-25 | Resumed | Stifel | Hold |
| Sep-08-25 | Initiated | Oppenheimer | Outperform |
| Aug-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Aug-07-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-09-25 | Downgrade | Citigroup | Neutral → Sell |
| Jun-16-25 | Initiated | Truist | Hold |
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Mar-05-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-28-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Oct-02-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-22-24 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-08-24 | Initiated | Canaccord Genuity | Buy |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Mar-26-24 | Upgrade | Stifel | Hold → Buy |
| Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
| May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-20-20 | Initiated | Wells Fargo | Overweight |
| Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-18-20 | Reiterated | Raymond James | Outperform |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-06-20 | Initiated | Raymond James | Outperform |
| Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-18-19 | Initiated | Guggenheim | Buy |
| Oct-04-19 | Upgrade | UBS | Neutral → Buy |
| May-17-19 | Reiterated | BofA/Merrill | Neutral |
| May-13-19 | Initiated | SVB Leerink | Outperform |
| Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-27-19 | Reiterated | Lake Street | Buy |
| Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-26-18 | Reiterated | Dougherty & Company | Buy |
| Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
Tandem Diabetes Care's Earnings Outlook - Benzinga
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Exploring A 37.96% Potential Upside - DirectorsTalk Interviews
Unlocking Q4 Potential of Tandem Diabetes Care (TNDM): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Understanding Momentum Shifts in (TNDM) - Stock Traders Daily
Did t:slim X2 Legal Probe Just Shift Tandem Diabetes Care's (TNDM) Disclosure and Risk Narrative? - simplywall.st
Tandem Diabetes Care Announces Upcoming Conference PresentationsFebruary 12, 2026 - BioSpace
Tandem Diabetes Care (TNDM) to Release Earnings on Thursday - MarketBeat
Diabetes Care Devices Market to Reach USD 42.1 Billion by 2028, Growing at a 4.8% CAGR - industrytoday.co.uk
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
Don't buy Tandem Diabetes Care until this big thing happens - MSN
Tandem Diabetes Care, Inc. (TNDM): Investor Outlook With A 38.40% Potential Upside - DirectorsTalk Interviews
Will Tandem Diabetes Care Inc. benefit from geopolitical trends2025 Key Highlights & Expert Verified Movement Alerts - mfd.ru
What’s the beta of Tandem Diabetes Care Inc. stockEarnings Summary Report & AI Enhanced Trading Signals - mfd.ru
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), ... - Bluefield Daily Telegraph
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors t - GuruFocus
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - PR Newswire
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Avoiding Lag: Real-Time Signals in (TNDM) Movement - Stock Traders Daily
Abbott on track with dual sensor, FDA warns on FreeStyle Libre - Modern Healthcare
Artificial Pancreas System Market is expected to reach US$ - openPR.com
Stifel Nicolaus Reaffirms Their Hold Rating on Tandem Diabetes Care (TNDM) - The Globe and Mail
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Breaking Down Tandem Diabetes Care: 12 Analysts Share Their Views - Benzinga
TNDM: Stifel Maintains Hold Rating, Raises PT to $20 | TNDM Stoc - GuruFocus
Stifel Nicolaus Issues Positive Forecast for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price - MarketBeat
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Momentum Shift - Sahm
Y Intercept Hong Kong Ltd Purchases Shares of 56,925 Tandem Diabetes Care, Inc. $TNDM - MarketBeat
United States Diabetes Devices Market to Reach US$ 19.44 Billion - openPR.com
Commit To Buy Tandem Diabetes Care At $13, Earn 14.2% Annualized Using Options - Nasdaq
Is Tandem Diabetes Care (TNDM) Starting To Look Attractive After Prolonged Share Price Weakness? - Yahoo Finance
Investment Review: Will Tandem Diabetes Care Inc stock benefit from M AJuly 2025 Price Swings & Stepwise Trade Signal Guides - baoquankhu1.vn
Energy Moves: Is Tandem Diabetes Care Inc forming bullish engulfing patternsWeekly Stock Analysis & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Can Tandem Diabetes Care Inc. generate free cash flowJuly 2025 Snapshot & Weekly Setup with High ROI Potential - mfd.ru
Why Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Could Be Worth Watching - 富途牛牛
Tandem Diabetes Care Inc (TNDM) Stock Price Down 4.17% on Jan 28 - GuruFocus
Pleasing Signs As A Number Of Insiders Buy Tandem Diabetes Care Stock - Yahoo Finance
Improved Growth Outlook and Better-Than-Expected Results Boosted Tandem Diabetes Care (TNDM) in Q4 - Insider Monkey
Rosen Law Firm Investigates Tandem Diabetes Securities Claims - Intellectia AI
TNDM Stock: TD Cowen Boosts Price Target and Reaffirms Buy Ratin - GuruFocus
Can Tandem Diabetes Care Inc stock double in the next yearInsider Selling & Weekly Setup with ROI Potential - baoquankhu1.vn
A Look At Tandem Diabetes Care (TNDM) Valuation After Legal Probe Into t:slim X2 Pump Correction - Sahm
Discipline and Rules-Based Execution in TNDM Response - Stock Traders Daily
3 Reasons to Avoid TNDM and 1 Stock to Buy Instead - Finviz
Analysts Have Conflicting Sentiments on These Healthcare Companies: Tandem Diabetes Care (TNDM), Qiagen (QGEN) and Siemens Healthineers AG (OtherSEMHF) - The Globe and Mail
TNDM INVESTOR NEWS: ROSEN, A LONGSTANDING FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - marketscreener.com
How Device Correction and Securities Probe Will Impact Tandem Diabetes Care (TNDM) Investors - Sahm
Aug Reactions: Will Tandem Diabetes Care Inc benefit from geopolitical trendsJuly 2025 Levels & Fast Gain Swing Alerts - baoquankhu1.vn
Does Tandem Diabetes Care Inc. (TD5A) stock trade below intrinsic value2025 Market Trends & Technical Pattern Recognition Alerts - bollywoodhelpline.com
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - TMX Newsfile
Diabetes warning issued over insulin pump error - MSN
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):